Charles River Laboratories International, Inc. (CRL)
NYSE: CRL · IEX Real-Time Price · USD
218.24
-0.34 (-0.16%)
At close: Jul 19, 2024, 4:00 PM
218.34
+0.10 (0.05%)
After-hours: Jul 20, 2024, 12:58 PM EDT

CRL Revenue

Charles River Laboratories International had revenue of $4.11B in the twelve months ending March 30, 2024, with 0.49% growth year-over-year. Revenue in the quarter ending March 30, 2024 was $1.01B. In the year 2023, Charles River Laboratories International had annual revenue of $4.13B with 3.86% growth.

Revenue (ttm)
$4.11B
Revenue Growth
+0.49%
P/S Ratio
2.73
Revenue / Employee
$188,605
Employees
21,800
Market Cap
11.24B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 30, 20234.13B153.35M3.86%
Dec 31, 20223.98B435.90M12.31%
Dec 25, 20213.54B616.23M21.08%
Dec 26, 20202.92B302.71M11.55%
Dec 28, 20192.62B355.13M15.67%
Dec 29, 20182.27B408.50M21.99%
Dec 30, 20171.86B176.17M10.48%
Dec 31, 20161.68B318.13M23.34%
Dec 26, 20151.36B65.64M5.06%
Dec 27, 20141.30B132.13M11.34%
Dec 28, 20131.17B36.00M3.19%
Dec 29, 20121.13B-13.12M-1.15%
Dec 31, 20111.14B9.23M0.81%
Dec 25, 20101.13B-38.23M-3.26%
Dec 26, 20091.17B-123.66M-9.55%
Dec 27, 20081.30B64.67M5.26%
Dec 29, 20071.23B172.24M16.27%
Dec 30, 20061.06B65.06M6.55%
Dec 31, 2005993.33M269.11M37.16%
Dec 25, 2004724.22M110.50M18.00%
Dec 27, 2003613.72M59.09M10.65%
Dec 28, 2002554.63M89.00M19.11%
Dec 29, 2001465.63M159.05M51.88%
Dec 30, 2000306.59M75.17M32.48%
Dec 25, 1999231.41M26.35M12.85%
Dec 26, 1998205.06M34.35M20.12%
Dec 27, 1997170.71M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fresenius Medical Care AG & Co. KGaA 21.17B
Universal Health Services 14.66B
DaVita 12.34B
Smith & Nephew 5.55B
Catalent 4.14B
Teleflex 3.00B
Globus Medical 1.90B
Bio-Techne 1.15B
Revenue Rankings